'Living Factories of the Future' Featured in Nature
- Posted on 17 March, 2016
A recent feature in Nature focuses on the various ways industry and academia hope to automate and industrialise Synthetic Biology, including SynbiCITE's upcoming DNA Foundry.
The SynbiCITE Foundry, which will be first Synthetic Biology DNA Foundry available for commercial use in Europe, will provide automated end-to-end design, construction and validation of synthetic biologic components using a suite of state-of-the-art robotic equipment.
The Foundry will provide synthetic biology manufacturing capabilities and training to organisations with innovative ways of using synthetic biology but without the facilities to develop them further.
Share this article:
People also read
Evonetix raises $30 million USD (£23 million GBP)
Series B investment led by west-coast investor Foresite Capital, with all existing investors participating in the roundFunds will be used to accelerat...
Evonetix collaborates with imec to scale-up chip-based technology production for third generation DNA synthesis platform
CAMBRIDGE, UK, and LEUVEN, Belgium, 13 January 2020 – EVONETIX LTD (‘Evonetix’), the synthetic biology company developing a desktop platform for scala...
Biotech firm MiAlgae secures £1m to turn whisky by-products into pet and fish food
An Edinburgh-based biotech startup which turns whisky distillation by-products into pet and fish food has received investment of £1 million.MiAlgae pr...